Atezolizumab With Nab-paclitaxel for Patients With Triple-negative Stage IV Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer Metastatic
Interventions: DRUG: Atezolizumab in combination with nab-paclitaxel
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS